Pitavastatina Stada 1 mg Film-Coated Tablets
Pitavastatina Stada 2 mg Film-Coated Tablets
Pitavastatina Stada 4 mg Film-Coated Tablets
Read this leaflet carefully before you start taking this medicine, because it contains important information for you.
This medication contains a substance called pitavastatina. It belongs to a group of medications called ‘statins’.
Pitavastatina is used to correct levels of fatty substances (lipids) in the blood and it can be taken by both children aged 6 years and older and adults. An imbalance of fats, especially cholesterol, may sometimes cause a heart attack or a cerebral infarction.
You have been prescribed pitavastatina because you have an imbalance of fats, and changes in your diet and lifestyle have not been sufficient to correct it. You must continue with a low-cholesterol diet and changes in your lifestyle while taking pitavastatina.
Do not take Pitavastatina Stada:
If you have any doubts, consult your doctor or pharmacist before starting to take pitavastatina.
Warnings and precautions
Consult your doctor or pharmacist before starting to take pitavastatina if:
If any of the above cases apply to you (or you have any doubts), consult your doctor or pharmacist before starting to take pitavastatina. Also, inform your doctor or pharmacist if you experience persistent muscle weakness. Additional tests and medications may be necessary to diagnose and treat this problem.
While you are taking this medication, your doctor will monitor whether you have diabetes or are at risk of developing diabetes. This risk of diabetes increases if you have high blood sugar and fat levels, obesity, and high blood pressure.
Children and adolescents
Pitavastatina should not be administered to children under 6 years old.
Before taking pitavastatina, adolescents should receive guidance and counseling on contraceptives.
Other medications and Pitavastatina Stada
Inform your doctor or pharmacist if you are taking or have taken recently or may need to take other medications, including those purchased without a prescription or herbal products. Some medications may make others less effective.
Specifically, inform your doctor or pharmacist if you are taking any of the following medications:
If any of the above cases apply to you (or you have any doubts), consult your doctor or pharmacist before starting to take this medication.
Pregnancy, breastfeeding, and fertility
Do not take pitavastatina if you are pregnant or breastfeeding. If you want to become pregnant, inform your doctor before starting to take pitavastatina.
If you are a woman and may become pregnant, you must use an effective contraceptive method while taking pitavastatina.If you become pregnant while taking pitavastatina, stop taking pitavastatina and see your doctor immediately.
If you are pregnant or breastfeeding, consult your doctor or pharmacist before starting to take any medication.
Driving and operating machinery
Pitavastatina is not expected to affect your ability to drive or operate machinery. However, if you feel dizzy or drowsy while taking pitavastatina, do not drive or operate machinery or tools.
Pitavastatina Stada contains lactose
This medication contains lactose (a type of sugar). If your doctor has told you that you have a certain sugar intolerance, consult with them before taking this medication.
Follow the medication administration instructions exactly as indicated by your doctor. If you are unsure, consult your doctor or pharmacist again.
Taking this medication
How much to take
Use in children and adolescents
Other things you need to know while taking Pitavastatina Stada
If you take more Pitavastatina Stada than you should
If you take more pitavastatina than you should, inform your doctor or go to the hospital immediately. Bring the medication packaging.
In case of overdose or accidental ingestion, consult your doctor or pharmacist or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Pitavastatina Stada
Do not worry, take the next dose at the correct time. Do not take a double dose to make up for the missed dose.
Stop taking Pitavastatina Stada and see your doctor immediately if you observe any of the following severe side effects, as you may need urgent medical treatment:
Other side effects include:
Frequent (affects less than 1 person in 10)
Rare (affects less than 1 person in 100)
Rare (affects less than 1 person in 1,000)
Side effects of unknown frequency (cannot be estimated from the available data)
* Consult your doctor if you experience weakness in the arms or legs that worsens after periods of activity, double vision, or eyelid drooping, difficulty swallowing, or difficulty breathing.
Other possible side effects
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Store in the original packaging (blister) to protect it from light..
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the blister and on the box after CAD. The expiration date is the last day of the month indicated.
Medicines should not be thrown into the drains or trash. Dispose of the containers and medications you no longer need at the SIGRE collection point of the pharmacy. Ask your pharmacist how to dispose of the containers and medications you no longer need. By doing so, you will help protect the environment.
Composition of Pitavastatina Stada
The active ingredient is pitavastatin (as pitavastatin calcium)
Each film-coated tablet contains 1 mg of pitavastatin (as pitavastatin calcium)
Each film-coated tablet contains 2 mg of pitavastatin (as pitavastatin calcium)
Each film-coated tablet contains 4 mg of pitavastatin (as pitavastatin calcium)
The other excipients are:
Core of the tablet
Lactose monohydrate, low-substituted hydroxypropylcellulose, hypromellose (E464), magnesium hydroxide, magnesium stearate
Coating
Opadry Y-1-7000 containing hypromellose (E464), titanium dioxide (E171), macrogol.
Appearance of the product and content of the container
Pitavastatina Stada 1 mg are film-coated tablets, round, biconvex, white, without a notch, and with the logo ‘P1’ on one side.
Pitavastatina Stada 2 mg are film-coated tablets, round, biconvex, white, without a notch, and with the logo ‘P2’ on one side.
Pitavastatina Stada 4 mg are film-coated tablets, round, biconvex, white, notched on one side, and with the logo ‘P4’ on the other side.
Pitavastatina Stada is available in packs of 7 and 28 tablets.
Only some container sizes may be marketed.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization
STADA Laboratorios, S.L.
Frederic Mompou, 5
08960 Sant Just Desvern (Barcelona)
Spain
Responsible for manufacturing
Laboratorios CINFA, S.A.
Carretera Olaz-Chipi, 10 Industrial Estate Areta,
31620 Huarte (Navarra) Spain
Or
STADA Arzneimittel AG
Stadastrasse 2 – 18
61118 Bad Vilbel
Germany
Last review date of this leaflet:September 2023
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.